down arrow

Dr Agarwal's Eye

  • Market Cap: Small Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE934C01018
  • NSEID:
  • BSEID: 526783
INR
4,057.75
7.75 (0.19%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 455

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

3,979.954,199.00

52 Week

2,800.007,300.00
Valuation
Technical
Day's Volume

CASH

455 (-44.98%) Volume

Shareholding (Dec 2024)

FII

0.84%

Held by 3 FIIs

DII

1.03%

Held by 0 DIIs

Promoter

71.90%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Flat results in Dec 24

  • INTEREST(HY) At Rs 7.52 cr has Grown at 48.62%
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 6.65 times
  • PBT LESS OI(Q) Lowest at Rs 11.75 cr.
2

Stock is technically in a Bearish range

3

55.45% of Promoter Shares are Pledged

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Hospital & Healthcare Services

stock-summary
Market cap

INR 1,907 Cr (Small Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

55

stock-summary
Dividend Yield

0.12%

stock-summary
Debt Equity

1.49

stock-summary
Return on Equity

32.74%

stock-summary
Price to Book

12.11

Revenue and Profits (1 Year):
Net Sales:
95 Cr
(Quarterly Results - Dec 2024)
Net Profit:
10 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.12%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-26.7%
0.05%
-26.65%
1 Year
21.45%
0.14%
21.59%
2 Years
237.01%
0.75%
237.76%
3 Years
460.04%
1.82%
461.86%
4 Years
1129.62%
3.58%
1133.2%
5 Years
1787.76%
6.14%
1793.9%

Latest dividend: 2.5 per share ex-dividend date: Nov-08-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.43%
EBIT Growth (5y)
26.14%
EBIT to Interest (avg)
5.84
Debt to EBITDA (avg)
2.02
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.50
Tax Ratio
25.91%
Dividend Payout Ratio
2.53%
Pledged Shares
55.45%
Institutional Holding
1.87%
ROCE (avg)
19.37%
ROE (avg)
23.46%
Valuation key factors
Factor
Value
P/E Ratio
37
Industry P/E
55
Price to Book Value
12.11
EV to EBIT
28.67
EV to EBITDA
19.20
EV to Capital Employed
5.46
EV to Sales
5.65
PEG Ratio
4.20
Dividend Yield
0.12%
ROCE (Latest)
16.47%
ROE (Latest)
32.74%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

55.4478

Mutual Funds

Held by 1 Schemes (0.05%)

FIIs

Held by 3 FIIs (0.84%)

Promoter with highest holding

Dr. Agarwal's Health Care Limited (71.9%)

Highest Public shareholder

Varun Ashok Hiremath (1.62%)

Individual Investors Holdings

20.44%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 25.23% vs 19.53% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 10.17% vs 86.56% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "95.11",
          "val2": "75.95",
          "chgp": "25.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.62",
          "val2": "20.77",
          "chgp": "23.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.85",
          "val2": "1.83",
          "chgp": "110.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.40",
          "val2": "9.44",
          "chgp": "10.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.94%",
          "val2": "27.35%",
          "chgp": "-0.41%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 24.33% vs 20.35% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 17.12% vs 32.73% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "202.21",
          "val2": "162.64",
          "chgp": "24.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "61.29",
          "val2": "45.86",
          "chgp": "33.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.70",
          "val2": "3.31",
          "chgp": "102.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "28.26",
          "val2": "24.13",
          "chgp": "17.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.31%",
          "val2": "28.20%",
          "chgp": "2.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 24.62% vs 20.09% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.16% vs 44.45% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "297.32",
          "val2": "238.59",
          "chgp": "24.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "86.91",
          "val2": "66.63",
          "chgp": "30.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.55",
          "val2": "5.14",
          "chgp": "105.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "38.66",
          "val2": "33.57",
          "chgp": "15.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.23%",
          "val2": "27.93%",
          "chgp": "1.30%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 19.10% vs 33.24% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 25.57% vs 53.20% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "319.30",
          "val2": "268.10",
          "chgp": "19.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "91.06",
          "val2": "74.90",
          "chgp": "21.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.17",
          "val2": "6.87",
          "chgp": "4.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "46.36",
          "val2": "36.92",
          "chgp": "25.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.52%",
          "val2": "27.94%",
          "chgp": "0.58%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
95.11
75.95
25.23%
Operating Profit (PBDIT) excl Other Income
25.62
20.77
23.35%
Interest
3.85
1.83
110.38%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.40
9.44
10.17%
Operating Profit Margin (Excl OI)
26.94%
27.35%
-0.41%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 25.23% vs 19.53% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 10.17% vs 86.56% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
202.21
162.64
24.33%
Operating Profit (PBDIT) excl Other Income
61.29
45.86
33.65%
Interest
6.70
3.31
102.42%
Exceptional Items
0.00
0.00
Standalone Net Profit
28.26
24.13
17.12%
Operating Profit Margin (Excl OI)
30.31%
28.20%
2.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 24.33% vs 20.35% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 17.12% vs 32.73% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
297.32
238.59
24.62%
Operating Profit (PBDIT) excl Other Income
86.91
66.63
30.44%
Interest
10.55
5.14
105.25%
Exceptional Items
0.00
0.00
Standalone Net Profit
38.66
33.57
15.16%
Operating Profit Margin (Excl OI)
29.23%
27.93%
1.30%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 24.62% vs 20.09% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 15.16% vs 44.45% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
319.30
268.10
19.10%
Operating Profit (PBDIT) excl Other Income
91.06
74.90
21.58%
Interest
7.17
6.87
4.37%
Exceptional Items
0.00
0.00
Standalone Net Profit
46.36
36.92
25.57%
Operating Profit Margin (Excl OI)
28.52%
27.94%
0.58%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 19.10% vs 33.24% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 25.57% vs 53.20% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Dr Agarwals Eye Hospital Ltd stock-summary
stock-summary
Dr Agarwals Eye Hospital Ltd
Small Cap
Hospital & Healthcare Services
Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994. The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the Company has been a pioneer and leader in the Indian Ophthalmology market with an established market position, healthy brand recall in the eye care segment.
Company Coordinates stock-summary
Company Details
3rd Floor Buhari Tower No 4, Moores Road Off Greams Road Chennai Tamil Nadu : 600006
stock-summary
Tel: 91-44-39916600
stock-summary
http://www.dragarwal.com
stock-summary
investor@dragarwal.com
Registrar Details
Integrated Enterprises (India) Ltd , II Floor , Kences Towers, No 1 Ramakrishna Street, North Usman Road, T Nagar, Chennai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."